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Background: Dietary fiber is beneficial for the treatment of type 2 diabetes mellitus, although it is consumed
differently in ethnic foods around the world. We investigated the association between dietary fiber intake and
obesity, glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese type 2 diabetic patients.
Methods: A total of 4,399 patients were assessed for dietary fiber intake using a brief self-administered diet history
questionnaire. The associations between dietary fiber intake and various cardiovascular risk factors were investigated
cross-sectionally.
Results: Body mass index, fasting plasma glucose, HbA1c, triglyceride and high-sensitivity C-reactive protein
negatively associated with dietary fiber intake after adjusting for age, sex, duration of diabetes, current smoking,
current drinking, total energy intake, fat intake, saturated fatty acid intake, leisure-time physical activity and use of
oral hypoglycemic agents or insulin. The homeostasis model assessment insulin sensitivity and HDL cholesterol
positively associated with dietary fiber intake. Dietary fiber intake was associated with reduced prevalence of
abdominal obesity, hypertension and metabolic syndrome after multivariate adjustments including obesity.
Furthermore, dietary fiber intake was associated with lower prevalence of albuminuria, low estimated glomerular
filtration rate and chronic kidney disease after multivariate adjustments including protein intake. Additional
adjustments for obesity, hypertension or metabolic syndrome did not change these associations.
Conclusion: We demonstrated that increased dietary fiber intake was associated with better glycemic control and
more favorable cardiovascular disease risk factors including chronic kidney disease in Japanese type 2 diabetic
patients. Diabetic patients should be encouraged to consume more dietary fiber in daily life.
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Diet rich in dietary fiber is beneficial for the treatment of
type 2 diabetes mellitus [1], as dietary fiber ameliorates
postprandial hyperglycemia by delaying digestion and
absorption of carbohydrates and enhances satiety, which
leads to a reduction in body weight [2]. In insulin-resistant
subjects, dietary fiber may enhance peripheral insulin
sensitivity possibly via short-chain fatty acids produced
by fermentation of fiber in the intestines [3-5]. The
hypoglycemic actions of dietary fiber in type 2 diabetic
patients have been investigated by conducting interventions
with high fiber diets or supplements [2]. In addition, an
epidemiologic study [6] recently reported that HbA1c
was significantly lower in type 2 diabetic patients with
high fiber intake than in those with low fiber intake among
934 Chinese subjects who ate foods containing larger
amounts of fiber than the Western diet [7].
As for cardiovascular disease (CVD) risk factors in type 2
diabetic patients, the effects of dietary fiber were not fully
explored. Soluble fiber forms gels in the gastrointestinal
tract, and may decrease the absorption of glucose and
cholesterol from the intestinal lumen [8]. High fiber diet
improved diabetic dyslipidemia in some studies [9], and
a low fiber intake was associated with metabolic syndrome
in Brazilian type 2 diabetic patients [10]. Although the
consumption of whole grains rich in insoluble fiber was
reported not to be associated with improvements in
glycemic control [9,11], it suppressed low-grade systemic
inflammation [12] and was inversely associated with all-
cause and CVD-specific mortality among diabetic females
in the Nurses’ Health Study [13]. Recently, it was reported
that increased dietary fiber, especially soluble fiber intake
was associated with reduced all-cause and CVD-specific
mortality in type 1 diabetic patients [14]. However, a
recent review reported that adding fiber supplements
in moderate amounts (4–19 g) to daily diet leads to little
improvement in glycemic or CVD risk markers, although
the effects of dietary fiber were investigated mostly in
subjects consuming Western diet [9]. Dietary fiber is
consumed differently in ethnic foods around the world,
and the protective effects of dietary fiber on the develop-
ment of diabetes differed by ethnic group according to
consumed foods [15]. Japanese foods consist of dietary
fiber primarily in the form of vegetables including seaweed,
and contain smaller amounts of fiber than Western diet,
of which the main source of fiber is whole grains [7,16].
It has been reported that increased intake of dietary
fiber is associated with reduced mortality from CVD in
the Japanese general population [17,18], although the ef-
fects of dietary fiber intake have not been investigated in
diabetic patients. In the present study, we investigated the
associations of dietary fiber intake with glycemic control
and CVD risk factors, i.e., metabolic syndrome, LDL
cholesterol, low-grade inflammation and chronic kidneydisease (CKD) in Japanese type 2 diabetic patients. This
cross-sectional study suggested the beneficial effects of




The Fukuoka Diabetes Registry is a multicenter prospect-
ive study designed to investigate the effects of modern
treatment on the prognosis of diabetic patients attending
teaching hospitals certified by the Japan Diabetes Society
or certified diabetes clinics in Fukuoka Prefecture, Japan
(UMIN Clinical Trial Registry 000002627) [19]. A total
of 5,131 diabetic patients 20 years of age or older were
registered between April 2008 and October 2010. After
excluding 261 subjects with type 1 diabetes mellitus,
468 subjects who had already eaten breakfast and three
subjects who reported consuming less than 500 kcal in a
dietary survey, the remaining 4,399 subjects (2,493 males,
1,906 females) were enrolled in this cross-sectional study.
The exclusion criteria were: 1) patients with drug-induced
diabetes and those receiving steroid treatment, 2) patients
under renal replacement therapy and 3) patients with ser-
ious diseases other than diabetes, such as advanced malig-
nancy, decompensated liver cirrhosis, etc. and 4) patients
unable to visit diabetologists regularly. This study was
conducted with the approval of the Kyushu University
Institutional Review Board, and written informed consent
was obtained from all participants.
Dietary assessment
The dietary survey was conducted using a brief self-
administered diet history questionnaire (BDHQ) to assess
the subjects’ dietary intake during the preceding month.
The BDHQ includes 58 foods and beverage items. The
subjects indicated their mean frequency of consumption
in terms of the specified serving size by checking one of
seven frequency categories ranging from “almost never” to
“two or more times a day” [20]. The dietary intake esti-
mates for total energy and several nutrients, including
dietary fiber, were calculated using an ad hoc algorithm
developed for the BDHQ based on the Standard Tables
of Food Composition in Japan [21]. Validation of ranking
energy-adjusted fiber intake has been previously stud-
ied in an adult Japanese population [22]. The correlation
coefficient of dietary fiber intake between semi-weighed
dietary records for 16 days and BDHQ was 0.66 in females
(n = 92) and 0.70 in males (n = 92), respectively.
Clinical evaluation
Participants completed a self-administered questionnaire
concerning the duration of diabetes mellitus, alcohol intake,
smoking habits and physical activity. Body mass index
(BMI) was calculated from each subject’s height and weight,
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Japan Society for the Study of Obesity [23]. Waist circum-
ference at the umbilical level was measured by a trained
staff member with the subject in the standing position,
and blood pressure was measured with the subject in
the sitting position. The subjects’ medical records were
reviewed for oral hypoglycemic agent and insulin use.
Leisure time physical activity information was obtained
using a self-reported questionnaire, and metabolic equiva-
lent (met) hours per week was calculated using Ainsworth’s
methods [24].
Laboratory measurements
Blood was collected via venipuncture. Spot urine samples
were obtained, and the assessments were performed at
one central laboratory. HbA1c was determined using
high-performance liquid chromatography (Tosoh Corp.,
Tokyo, Japan), plasma glucose by glucose oxidase method,
serum C-peptide by chemiluminescent immunoassay
(Kyowa Medex, Tokyo, Japan), serum adiponectin and high
sensitivity C-reactive protein (HS-CRP) by latex immuno-
nephelometry (Mitsubishi Chemical Medience, Tokyo,
Japan; Siemens Healthcare Diagnostics, Tokyo, Japan),
urinary albumin by immunonephelometry (Medical and
Biological Laboratories, Nagoya, Japan) and serum total
cholesterol, LDL cholesterol, HDL cholesterol, triglyceride,
creatinine and urine creatinine by enzymatic methods.
Estimated glomerular filtration rate (eGFR) was calculated
using the equation proposed by the Japanese Society of
Nephrology [25]. β cell function and insulin sensitivity
were estimated based on fasting glucose and C-peptide
concentrations using the HOMA Calculator, version
2.2.2 [http://www.dtu.ox.ac.uk, accessed June 2012], and
expressed as the homeostasis model assessment β cell
function (HOMA2-%B) and the homeostasis model as-
sessment insulin sensitivity (HOMA2-%S), respect-
ively. A total of 587 participants with unacceptable levels
of plasma glucose (<3 mmol/l or >25 mmol/l) or C-peptide
(<0.2 nmol/l or >3.5 nmol/l) were excluded [26]. Albumin-
uria was defined as urinary albumin excretion ≥30 mg/gCr,
and CKD was defined as albuminuria and/or eGFR <60 ml/
min/1.73 m2 [27]. Metabolic syndrome was defined ac-
cording to the definition of “Harmonizing the Metabolic
Syndrome” [28], i.e., the presence of at least two of the
following four components: central obesity for Asians
(waist circumference ≥90 cm in males and ≥80 cm in
females), elevated triglycerides (≥1.69 mmol/l and/or
the use of triglyceride-lowering drugs), reduced HDL
cholesterol (<1.03 mmo/l in males and <1.29 mmol/l
in females) and elevated blood pressure (systolic blood
pressure ≥130 mmHg and/or diastolic blood pres-
sure ≥85 mmHg and/or the use of antihypertensive drugs).
The presence of depressive symptoms was assessed
using the Center for Epidemiologic Studies DepressionScale [29], and subjects who scored more than 16 out of
60 points were defined as having depressive symptoms.
Statistical analysis
The correlations with dietary fiber intake were assessed by
Pearson’s correlation for continuous variables and a logistic
regression analysis for categorical variables. The regression
coefficients and 95% CIs' were calculated using a multiple
regression analysis after multivariate adjustment for poten-
tial confounding factors, including age, sex, duration of dia-
betes, current smoking habits, current drinking habits, total
energy intake, fat intake, saturated fatty acid intake, protein
intake (only for urinary albumin excretion and eGFR),
leisure time physical activity and use of oral hypoglycemic
agents or insulin. Due to their skewed distributions, tri-
glyceride, adiponectin and urinary albumin excretion values
were log transformed, and the results were expressed
as geometric means with 95% CIs. The multivariate-
adjusted ORs and 95% CIs for metabolic syndrome and
chronic kidney disease were calculated using a multiple
logistic regression model. All statistical analyses were
performed using the SAS software package version 9.3
(SAS Institute Inc., Cary, NC). Values of P <0.05 were con-
sidered to be statistically significant in all of the analyses.
Results
Table 1 shows the clinical characteristics of the studied
participants and correlations with dietary fiber intake.
Regarding the source of dietary fiber, vegetables were most
frequently eaten, followed by cereals, legumes and beans
and fruits, as reported previously in the general population
in Japan [16]. Age, fat and protein intakes and leisure time
physical activity were positively associated with dietary fiber
intake. The proportions of males, current smokers, current
drinkers, saturated fatty acid intake and the proportion
of participants with depressive symptoms were nega-
tively associated with dietary fiber intake. However, the
duration of diabetes and treatment for diabetes were
not associated with dietary fiber intake.
As shown in Table 2, BMI, waist circumference, fasting
plasma glucose (FPG), HbA1c, fasting serum C-peptide,
HS-CRP, triglyceride, systolic blood pressure and urinary
albumin excretion were significantly and negatively associ-
ated with dietary fiber intake after adjusting for age, sex,
duration of diabetes, current smoking habits, current drink-
ing habits, total energy intake, fat intake, saturated fatty acid
intake, protein intake (only for urinary albumin excretion),
leisure time physical activity and use of oral hypoglycemic
agents or insulin. The insulin sensitivity index HOMA2%-S,
HDL cholesterol and eGFR were significantly and posi-
tively associated with dietary fiber intake after multivariate
adjustments including protein intake (only for eGFR).
The insulin secretion index HOMA2%-B, adiponectin,
total cholesterol, LDL cholesterol and diastolic blood
Table 1 Characteristics of the studied participants and correlations with dietary fiber intake
Mean or percentage Correlation coefficient or odds ratio p
Number 4,399
Dietary fiber intake (g/1,000 kcal) 7.60 ± 0.03 -
Fiber from vegetables (%) 47.1 ± 0.2 0.42* <0.0001
Fiber from cereals (%) 22.5 ± 0.2 −0.60* <0.0001
Fiber from legumes and beans (%) 11.8 ± 0.1 0.11* <0.0001
Fiber from fruits (%) 9.5 ± 0.1 0.15* <0.0001
Age (years) 65.4 ± 0.2 0.18* <0.0001
Sex (male, %) 56.7 0.76 [0.74-0.78]# <0.0001
Duration of diabetes (years) 15.5 ± 0.2 0.00* ns
Current smoker (%) 18.3 0.79 [0.76-0.82]# <0.0001
Current drinker (%) 38.8 0.77 [0.74-0.79]# <0.0001
Total energy intake (kcal) 1689 ± 7 −0.12* <0.0001
Fat intake (g/day) 52.4 ± 0.3 0.09* <0.0001
Saturated fatty acid intake (g/day) 12.3 ± 0.1 −0.08* <0.0001
Protein intake (g/day) 67.3 ± 0.4 0.04* 0.006
Leisure-time physical activity (met・hr/week) 11.8 ± 0.2 0.12* <0.0001
Depressive symptoms (%) 8.9 0.95 [0.90-0.99]# 0.035
Oral hypoglycemic agents (%) 64.1 0.99 [0.96-1.01]# ns
Insulin therapy (%) 27.1 0.98 [0.95-1.01]# ns
Mean ± SE. *correlation coefficient, #odds ratio with 95% CI.
Table 2 Multiple regression analysis of dietary fiber intake with clinical and laboratory variables
Variables Mean Regression coefficient p for trend
Body mass index (kg/m2) 23.8 ± 0.06 −0.18 [−0.24,-0.11] <0.0001
Waist circumference (cm) 85.9 ± 0.2 −0.56 [−0.73,-0.39] <0.0001
Fasting plasma glucose (mmol/l) 7.73 ± 0.03 −0.049 [−0.084,-0.014] 0.007
HbA1c (%) 7.42 ± 0.02 −0.022 [−0.038,-0.005] 0.009
HbA1c (mmol/mol) 57.6 ± 0.2 −0.24 [−0.42,-0.06] 0.009
Fasting serum C-peptide (nmol/l) 0.402 ± 0.003 −0.009 [−0.013,-0.006] <0.0001
HOMA2%-B 45.7 ± 0.4 −0.26 [−0.68, 0.17] ns
HOMA2%-S 106.0 ± 0.6 1.95 [1.27, 2.62] <0.0001
Adiponectin (μg/ml)* 9.1 [8.9-9.2] 0.006 [−0.003, 0.016] ns
HS-CRP (mg/l)* 0.50 [0.48-0.52] −0.067 [−0.090,-0.043] <0.0001
Total cholesterol (mmol/l) 4.99 ± 0.01 0.009 [−0.005, 0.023] ns
LDL cholesterol (mmol/l) 2.87 ± 0.01 0.010 [−0.002, 0.022] ns
HDL cholesterol (mmol/l) 1.47 ± 0.01 0.008 [0.001, 0.014] 0.017
Triglyceride (mmol/l)* 1.22 [1.20-1.24] −0.013 [−0.022,-0.005] 0.003
Systolic blood pressure (mmHg) 130.7 ± 0.3 −0.35 [−0.64,-0.06] 0.017
Diastolic blood pressure (mmHg) 74.7 ± 0.2 −0.05 [−0.22, 0.13] ns
Urinary albumin excretion (mg/g) 28.2 [26.8-29.7] −0.092 [−0.121,-0.063] <0.0001
eGFR (ml/min/1.73 m2) 75.0 ± 0.3 0.34 [0.01, 0.67] 0.042
Mean ± SE. *Geometric means with 95% CI in brackets. HOMA2-%B, homeostasis model assessment β-cell function; HOMA2-%S, homeostasis model assessment
insulin sensitivity; HS-CRP, high sensitivity-C reactive protein; eGFR, estimated glomerular filtration rate. The multivariate adjustment included age, sex, duration of
diabetes, current smoking habits, current drinking habits, total energy intake, fat intake, saturated fatty acid intake, protein intake (only for urinary albumin
excretion and eGFR), leisure time physical activity and use of oral hypoglycemic agents or insulin.
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fiber intake.
The results of multiple logistic analysis between metabolic
syndrome and dietary fiber intake are shown in Table 3.
The prevalence of obesity, abdominal obesity, hypertension,
hypertriglyceridemia, low HDL cholesterol and metabolic
syndrome in the study participants was 31.2%, 47.0%, 73.9%,
29.2%, 18.2% and 54.5%, respectively. Abdominal obesity
and hypertension were negatively associated with dietary
fiber intake after multivariate adjustments, and further
adjustment with obesity did not change the trends.
Hypertriglyceridemia and low HDL cholesterol were
not associated with dietary fiber intake. Consequently,
metabolic syndrome was negatively associated with dietary
fiber intake after multivariate adjustment with additional
adjustment for obesity.
The results of multiple logistic analysis between chronic
kidney disease and dietary fiber intake are shown in Table 4.
The prevalence of albuminuria, low eGFR and chronic
kidney disease in the study participants was 38.4%, 21.5%
and 46.9%, respectively. Albuminuria, low eGFR and CKD
were negatively associated with dietary fiber intake
after multivariate adjustments. These trends were not
significantly affected by additional adjustment for obesity,
hypertension or metabolic syndrome.
Discussion
The present study demonstrated that dietary fiber intake
was associated with better glycemic control and more
favorable CVD risk factors including abdominal obesity,
hypertension and metabolic syndrome, along with en-
hanced insulin sensitivity and reduced HS-CRP after
adjusting for confounding factors. Furthermore, the
proportion of participants with CKD negatively associated
with dietary fiber intake, even after adjusting for obesity,Table 3 Multiple logistic analysis between metabolic syndrom
Elevated waist circumference Model
Model + obesity








Obesity: BMI ≥25.0 kg/m2; Elevated waist circumference, waist circumference ≥90 c
pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg and/or the use of ant
and/or the use of triglyceride-lowering drugs; Low HDL cholesterol, fasting serum HDL c
was defined according to the definition of “Harmonizing the Metabolic Syndrome.” Mod
habits, current drinking habits, total energy intake, fat intake, saturated fatty acid intake,hypertension or metabolic syndrome. To the best of our
knowledge, there are few epidemiological studies showing
associations of dietary fiber intake with glycemia and
CVD risk factors in Asia, where the epidemic of type 2
diabetes is rapidly becoming a serious medical and so-
cioeconomic issue.
A recent systematic review of the literature reported that
adding fiber supplements in moderate amounts (4–19 g)
to daily diet achieved little improvement in glycemic con-
trol or CVD risk factors [9]. On the other hand, another
meta-analysis [2] of intervention trials using high fiber diet
(mean increase in fiber 18.3 g/d) in type 2 diabetic patients
revealed that FPG and HbA1c were modestly lowered
by 0.83 mmol/l and 0.26%, respectively, compared with
a placebo. In the present study, both FPG and HbA1c
negatively associated with dietary fiber intake (Table 2). In
addition, the insulin sensitivity index HOMA2%-S and
HS-CRP were associated with dietary fiber intake and the
association remained statistically significant after the
additional adjustment for BMI (regression coefficient 1.34
[0.71, 1.97], -0.048 [−0.070,-0.025], respectively). Although
the effects of dietary fiber on insulin sensitivity have not
been studied in type 2 diabetic patients, dietary fiber en-
hances insulin sensitivity in hepatic and peripheral tissues
in insulin-resistant obese subjects [3-5].
It was recently reported that the consumption of high
fiber diet for four weeks enhanced insulin secretion in
nondiabetic overweight subjects [30]. Dietary fiber may
activate incretin secretion due to short-chain fatty acid
production induced by the fermentation of dietary fiber
[31], although, in one study, it took one year for high
fiber diet to enhance glucagon-like peptide-1 secretion
in healthy subjects [32]. In the present study, the insulin
secretion index HOMA2%-B was not associated with diet-
ary fiber intake, suggesting that it is unlikely that insuline and dietary fiber intake











m in males and ≥80 cm in females; Elevated blood pressure, systolic blood
ihypertensive drugs; Elevated triglyceride, fasting serum triglyceride ≥1.69 mmol/l
holesterol <1.03 mmol/l in males and <1.29 mmol/l in females. Metabolic syndrome
el, multivariate adjustments with age, sex, duration of diabetes, current smoking
leisure time physical activity and use of oral hypoglycemic agents or insulin.
Table 4 Multiple logistic analysis between chronic kidney disease and dietary fiber intake
Odds ratio p for trend
Albuminuria ≥30 mg/g Model 0.92 [0.88-0.95] <0.0001
Model + obesity 0.93 [0.89-0.96] <0.0001
Model + elevated blood pressure 0.93 [0.89-0.96] <0.0001
Model + metabolic syndrome 0.93 [0.89-0.96] <0.0001
eGFR < 60 ml/min/1.73 m2 Model 0.94 [0.90-0.98] 0.006
Model + obesity 0.95 [0.90-0.99] 0.015
Model + elevated blood pressure 0.95 [0.91-0.99] 0.019
Model + metabolic syndrome 0.95 [0.91-0.99] 0.027
Chronic kidney disease Model 0.93 [0.90-0.96] <0.0001
Model + obesity 0.94 [0.90-0.97] 0.0005
Model + elevated blood pressure 0.94 [0.91-0.97] 0.0009
Model + metabolic syndrome 0.94 [0.91-0.98] 0.0011
Obesity: BMI ≥25.0 kg/m2; Elevated waist circumference, waist circumference ≥90 cm in males and ≥80 cm in females; Elevated blood pressure, systolic blood
pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg and/or the use of antihypertensive drugs; Elevated triglyceride, fasting serum triglyceride ≥1.69 mmol/l
and/or the use of triglyceride-lowering drugs; Low HDL cholesterol, fasting serum HDL cholesterol <1.03 mmol/l in males and <1.29 mmol/l in females. Metabolic syndrome
was defined according to the definition of “Harmonizing the Metabolic Syndrome.” Model, multivariate adjustments with age, sex, duration of diabetes, current
smoking habits, current drinking habits, total energy intake, fat intake, saturated fatty acid intake, protein intake, leisure time physical activity and use of oral
hypoglycemic agents or insulin.
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tributes to improving hyperglycemia.
In general, dietary fiber favorably affects CVD risk factors,
including LDL cholesterol [33] and components of meta-
bolic syndrome [34,35]. In type 2 diabetic patients, a recent
review reported that high fiber diet failed to affect the lipid
levels in four out of eight randomized controlled studies
[9]. In the present study, total cholesterol and LDL chol-
esterol were not associated with dietary fiber intake.
However, HDL cholesterol and triglyceride were signifi-
cantly associated with dietary fiber intake. Dietary fiber
exerts blood pressure-lowering effects [36,37], and recently,
Jenkins et al. [38] reported that high fiber and low glycemic
index diet with legumes reduced blood pressure compared
with wheat fiber diet in type 2 diabetic patients. In the
present study, systolic blood pressure and hypertension
were negatively associated with dietary fiber intake. En-
hanced insulin sensitivity may contribute to the blood
pressure-lowering effects of dietary fiber. As a result,
the prevalence of metabolic syndrome was significantly
associated with dietary fiber intake. Reduced fiber intake,
particularly at breakfast, was found to be associated
with metabolic syndrome in Brazilian type 2 diabetic
patients [10,39], although the authors did not report
which component of metabolic syndrome was associated
with low fiber intake. The present study demonstrated that
dietary fiber intake was associated with reduced preva-
lence of abdominal obesity and hypertension of metabolic
syndrome phenotypes independent of obesity. A reduction
in abdominal obesity induced by increased dietary fiber
intake has been reported in both intervention [40,41] andepidemiological studies [42]. However, the direct effects
of dietary fiber on visceral adipose tissue remain to be
elucidated.
CKD is an established CVD risk factor. The present study
demonstrated the association between dietary fiber intake
and lower prevalence of CKD (Table 4). Due to the cross-
sectional nature of the study, preventing hyperkalemia in
the advanced stage of CKD may limit the consumption of
fresh fruits and green vegetables. Indeed, in this study,
the proportion of participants with eGFR < 30 ml/min/
1.73 m2 was negatively associated with dietary fiber intake
(odds ratio 0.83 [0.76-0.91]). However, excluding par-
ticipants with eGFR < 30 ml/min/1.73 m2 (n = 115) did
not change the results (odds ratio 0.94 [0.91-0.97]). CVD
risk factors, such as obesity, hypertension and metabolic
syndrome, may contribute to the development and progres-
sion of CKD. However, adjusting for each CVD risk factor
did not change the significant association between dietary
fiber intake and CKD (Table 4). Although the mechanisms
of action of dietary fiber in the kidneys are unknown, high
dietary fiber intake is associated with a lower level of
systemic micro-inflammation in both nondiabetic and
diabetic patients [8,12], as shown in the present study
(Table 2). The anti-inflammatory actions of dietary fiber
may be related to reduced prevalence of CKD. Recently, a
large follow-up study showed that increased dietary fiber
intake was associated with reduced mortality in CKD
patients [43]. In this context, dietary fiber appears to be
promising non-pharmacological treatment for CKD.
The strength of the present study includes a relatively
large sample size of type 2 diabetic patients consuming
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Japanese diet is white rice, which has lower dietary fiber
than whole grains. The amount of daily fiber intake in
Japan declined from 20.5 g/d to 15 g/d after World War II
[44] to a level that is lower than that observed in the US
and UK [7]. The main source of dietary fiber of Japanese
people is vegetables including seaweed, a typical Japanese
food, followed by cereals, legumes and fruits [16]. The
present study showed that the dietary fiber present in
Japanese foods exerts beneficial effects on glycemia and
CVD risk factors, thus suggesting that the usefulness
of increased dietary fiber intake may extend beyond
certain ethnic foods. Another strength of the study is
that confounding factors included fat and saturated fatty
acid intakes and physical activity, since high dietary fiber
intake is often associated with healthy lifestyle, making it
difficult to isolate fiber effects from general healthy life-
style [14]. However, some limitations should be discussed.
First, the use of a self-administered food frequency dietary
assessment questionnaire BDHQ is subject to measure-
ment error in dietary intake, and actual dietary habits may
not be obtained. However, the ability to rank dietary fiber
using the BDHQ has been reasonably verified [22]. Second,
study participants who visit diabetologists regularly may
be better educated about self-management of diabetes
with respect to diet than the general population. However,
the daily fiber intake of the study participants was similar
to that of the general population in Japan (15 g/d). Third,
since multiple outcomes were involved in the present
study, multiple testing may induce false results. Finally,
we cannot prove cause-and-effect relationships due to
the cross-sectional design of our study, and there may
be other confounding factors in addition to those evalu-
ated in the present study.
Conclusion
We demonstrated that increased dietary fiber intake was
associated with better glycemic control and more favor-
able CVD risk factors including hypertension, metabolic
syndrome and CKD, along with improvements in insulin
sensitivity and micro-inflammation, in Japanese type 2
diabetic patients after adjusting for confounding factors.
Although the recommended amount of dietary fiber in
the general population is >19 g/d for males and >17 g/d
for females in Japan [45] and >38 g/d for males and >25 g/d
for females in the US [46], diabetic patients should be
encouraged to consume more dietary fiber in daily life
according to the ethnic foods.
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